Floatz logo

CYCLOSPORIN A

Natural Killer Cell Lymphoblastic Leukemia/Lymphoma

Medical College of Wisconsinprotein_peptidePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Natural Killer Cell Lymphoblastic Leukemia/Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
New York Medical College
Phase 3BBB
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 3BB
Umbilical Cord Blood Mononuclear Cells
Masonic Cancer Center, University of Minnesota
Phase 2B
Rapamycin
Masonic Cancer Center, University of Minnesota
Phase 2B
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 26 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →